President Joe Biden on April 5 tasked the U.S. health department with developing a national action plan to tackle the looming health crisis of long COVID, a complex, multi-symptom condition that leaves many of its sufferers unable to work.

People may be at increased risk for developing diabetes for up to a year after a diagnosis of COVID-19, according to two studies. Additionally, organ donation from dying donors with current or previous COVID-19 infection is likely safe, transplant teams from the United States and Italy will report at the April 2022 European Congress of Clinical Microbiology & Infectious Diseases meeting.

Moderna

Researchers from Harvard University and the U.S. Department of Veterans Affairs (VA) found that the Moderna mRNA vaccine was slightly better than the Pfizer-BioNTech vaccine.

The U.S. Veterans Health Administration will not include Aduhelm, the $56,000-a-year Alzheimer’s drug made by Biogen Inc. and Eisai Co. Ltd., on the VHA’s list of approved products due to a lack of evidence that the medicine is effective as well as safety concerns, the agency said on Aug. 11.

Shares of Gilead Sciences Inc. rose after the company’s antiviral drug remdesivir became the first approved treatment for Covid-19 in the United States.

The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine candidates in an effort to deliver a safe and effective one by the end of 2020, scientists leading the program told Reuters.

  Diversity of Women Veterans’ Experiences Myths vs Reality   In this paper, we tackle one of the most common myths about VA healthcare.   At Ipsos Public Affairs, we partner with the Department of Veterans Affairs (VA) to understand how Veterans utilize and experience VA healthcare services. Women are projected to be the fastest-growing […]

In January 2018, it was announced that five healthcare systems were launching a not-for-profit generic drug company. That company now has a name, Civica Rx.

Researchers have discovered a protein that could help diagnose a degenerative brain disease commonly found in athletes, veterans of military service and others who have experienced brain trauma.